KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Gilead Sciences (GILD) Accumulated Depreciation & Amortization (2016 - 2025)

Gilead Sciences' Accumulated Depreciation & Amortization history spans 17 years, with the latest figure at $2.7 billion for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 9.15% year-over-year to $2.7 billion; the TTM value through Dec 2025 reached $2.7 billion, up 9.15%, while the annual FY2025 figure was $2.7 billion, 9.15% up from the prior year.
  • Accumulated Depreciation & Amortization reached $2.7 billion in Q4 2025 per GILD's latest filing, roughly flat from $2.7 billion in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $2.7 billion in Q4 2025 to a low of $1.9 billion in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $2.4 billion, with a median of $2.5 billion recorded in 2024.
  • Peak YoY movement for Accumulated Depreciation & Amortization: rose 15.48% in 2022, then increased 0.86% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $1.9 billion in 2021, then rose by 15.48% to $2.2 billion in 2022, then increased by 12.03% to $2.4 billion in 2023, then rose by 0.86% to $2.5 billion in 2024, then rose by 9.15% to $2.7 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Accumulated Depreciation & Amortization are $2.7 billion (Q4 2025), $2.7 billion (Q3 2025), and $2.6 billion (Q2 2025).